Murad Acne Treatment

Murad Acne Treatment

#1 Branded Topical Acne Product, Epiduo(R) Gel, Receives FDA Approval for a New Convenient Pump Dispenser

FORT WORTH, TX —
Galderma Laboratories, L.P. currently perceived capitulation from a U.S. Food and Drug Administration (FDA) for a siphon dispenser for Epiduo® (adapalene and benzoyl peroxide) Gel 0.1% / 2.5%. This capitulation outlines a first-ever siphon dispenser for Epiduo Gel, a usually once-daily, accepted acne diagnosis that combines dual timeless active mixture adapalene, a retinoid, and benzoyl peroxide, a obvious antimicrobial with no justification of compelling bacterial resistance, for patients 12 years of age and older. Epiduo Gel is a #1 branded accepted acne product among dermatologists and pediatricians.(1) The Epiduo Gel siphon will be accessible around medication in a initial entertain of 2012 in pharmacies nationwide.

“Because acne is caused by a crowd of factors, government of a condition has traditionally relied on multiple therapy,” pronounced Dr. Linda Stein Gold, Director, Dermatology Clinical Research, Henry Ford Health System, Detroit, and Division Head, Dermatology, Henry Ford Health System, West Bloomfield. “As a dermatologist we mostly allot Epiduo Gel, that combines dual effective drugs into one product to provide both inflammatory and non-inflammatory lesions topically. My patients have mostly achieved really certain results, and we trust that patients will be vehement about a new siphon smoothness complement for a welfare and administration benefits.”

Studies prove that Epiduo Gel is some-more influential than possibly of a components used alone, and has had no justification of compelling antibiotic resistance. Epiduo Gel simplifies a government of acne and significantly reduces sum acne lesions by approximately 18 percent as early as a initial week of treatment. Epiduo Gel also helps to revoke a complexity of acne government by shortening a series of drugs a studious has to remember to take on a daily basis, potentially augmenting diagnosis adherence.

In a recently finished welfare survey, 92 percent of patients were confident or really confident with a new siphon for Epiduo Gel.(2a) The survey, that guarded studious welfare for a Epiduo Gel siphon vs. a tube, concerned 291 physician-diagnosed acne patients, ages 12 to 35.(2b, 2c) The randomized investigate found that with use of a Epiduo Gel pump, patients found it to be some-more convenient, easier to use and some-more appealing than a tube.(2d) Of note, a investigate resolved that:

  • Nearly 80 percent of patients pronounced they would ask a siphon over a tube a subsequent time they revisit their doctor.(2e)
  • 88 percent of patients pronounced a Epiduo Gel siphon done it easier for them to follow their doctor’s instructions.(2f)
  • More than 90 percent of patients found a Epiduo Gel siphon to broach a unchanging volume of a jelly to their face during any use, and also to save time during diagnosis administration.(2g)
  • 93 percent of patients pronounced a Epiduo Gel siphon was some-more appealing than a tube; in fact, 84 percent of patients pronounced they were some-more expected to leave a Epiduo Gel siphon out on a counter. (2h)

About Acne

Acne vulgaris is one of a many widely gifted ongoing skin diseases. In new years, investigate has lead to a larger bargain of a pathogenesis of a disease.(3) The commotion starts with a conflict of adolesence and is suspicion to outcome from hormonal movement on a skin’s oil glands (sebaceous glands) heading to plugged pores and outbreaks.(4) It can be severe to conduct due to a variability in response to diagnosis and a need for prolonged tenure therapy.(5)

About Galderma

Galderma, combined in 1981 as a corner try between Nestle and L’Oréal, is a fully-integrated specialty curative association dedicated exclusively to a margin of dermatology. The Company has a participation in 65 countries with over 1,000 sales member and is committed to improving a health of skin with an endless line of products opposite a universe that provide a operation of dermatological conditions including: acne, rosacea, fungal spike infections, psoriasis and steroid-responsive dermatoses, pigmentary disorders, medical solutions for skin senescence and skin cancers. With a investigate and growth core in Sophia Antipolis, France, Galderma has one of a largest RD comforts dedicated exclusively to dermatology. Leading U.S. brands embody Epiduo® Gel, Differin® Gel, 0.3%, Differin® Lotion, 0.1%, MetroGel® 1%, Oracea®, Cetaphil®, Tri-Luma® Cream, and Vectical® Ointment.

For some-more information about Galderma, greatfully revisit www.galderma.com.

Important Safety Information

Epiduo® Gel is indicated for a accepted diagnosis of acne vulgaris in patients 12 years and older. Apply to influenced skin once per day, avoiding a eyes, lips and mucous membranes. The many common inauspicious events compared with use of Epiduo® Gel are redness, scaling, dryness, severe and burning. In addition, we might also knowledge hit rash and/or skin irritation. These side effects typically solve during a initial 4 weeks of treatment, though pronounce to your alloy if they persist. You should equivocate extreme bearing to object and sunlamps while regulating Epiduo® Gel, and regulating sunscreen products and protecting wardrobe is recommended. Do not use vitriolic accepted products that enclose resorcinol, salicylic poison or sulfur when regulating Epiduo® Gel. Epiduo® Gel has not been tested in profound or nursing women, or with a elderly. Please see Full Prescribing Information.

You are speedy to news disastrous side effects of medication drugs to a FDA. Visitwww.fda.gov/medwatch or call 1-800-FDA-1088.

References:

(1) Galderma Data on File.

(2) Galderma Laboratories, L.P. Clinical Study Report (Gli.04.Sre.Us10184). Aug 2011.

(3) Gollnick H, Cunliffe WJ, Berson D et al. Management of Acne: A Report From a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003; 49(1):S1-S37.

(4) Nemours Foundation. Why Do we Get Acne? http://www.kidshealth.org/teen/your_body/skin_stuff/acne.html.

(5) Thiboutot D, Pariser DM, Egan N et al. Adapalene jelly 0.3% for a diagnosis of acne vulgaris: A multicenter, randomized, double-blind, tranquil trial. J Am Acad Dermatol. 2006; 54:242-50.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=1832730

© Marketwire 2011

Incoming search terms for the article:

Categories: Acne
16 December 2011 at 02:58 - Comments